Abstract
Caveolae are 50-100 nm cell surface plasma membrane invaginations that are highly enriched in cholesterol and sphingolipids and are characterized by the protein marker caveolin-1. Caveolin-1 is highly expressed in terminally differentiated cells. Among these cells, endothelial cells, smooth muscle cells, and macrophages have all been shown to play key roles in the development of vascular disease. Atherosclerosis and neointimal formation are two major processes that have been associated with arterial occlusion. In both cases, caveolin-1 has been shown to play an important role. However, depending on the cell type and the metabolic pathways regulated by this protein, caveolin-1 may positively or negatively influence the development of vascular disease. Both of these aspects will be discussed in this review.
Keywords: Caveolin, caveolae, atherosclerosis, transcytosis, lipoproteins, vascular disease
Current Pharmaceutical Design
Title: Caveolae and Caveolin-1: Novel Potential Targets for the Treatment of Cardiovascular Disease
Volume: 13 Issue: 17
Author(s): Philippe G. Frank, Ghada S. Hassan, Juan A. Rodriguez-Feo and Michael P. Lisanti
Affiliation:
Keywords: Caveolin, caveolae, atherosclerosis, transcytosis, lipoproteins, vascular disease
Abstract: Caveolae are 50-100 nm cell surface plasma membrane invaginations that are highly enriched in cholesterol and sphingolipids and are characterized by the protein marker caveolin-1. Caveolin-1 is highly expressed in terminally differentiated cells. Among these cells, endothelial cells, smooth muscle cells, and macrophages have all been shown to play key roles in the development of vascular disease. Atherosclerosis and neointimal formation are two major processes that have been associated with arterial occlusion. In both cases, caveolin-1 has been shown to play an important role. However, depending on the cell type and the metabolic pathways regulated by this protein, caveolin-1 may positively or negatively influence the development of vascular disease. Both of these aspects will be discussed in this review.
Export Options
About this article
Cite this article as:
Frank G. Philippe, Hassan S. Ghada, Rodriguez-Feo A. Juan and Lisanti P. Michael, Caveolae and Caveolin-1: Novel Potential Targets for the Treatment of Cardiovascular Disease, Current Pharmaceutical Design 2007; 13 (17) . https://dx.doi.org/10.2174/138161207780831202
DOI https://dx.doi.org/10.2174/138161207780831202 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
cGMP Signaling, Phosphodiesterases and Major Depressive Disorder
Current Neuropharmacology The Clinics and Etiology of Preeclampsia
Current Women`s Health Reviews Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease
Current Vascular Pharmacology cGMP-Dependent Protein Kinase in Regulation of the Pulmonary Circulation
Current Respiratory Medicine Reviews Subject Index To Volume 2
Current Women`s Health Reviews Dietary Approaches and Alternative Therapies for Rheumatoid Arthritis
Current Nutrition & Food Science VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Safety Issues of Vitamin D Supplementation
Anti-Cancer Agents in Medicinal Chemistry Air Pollution, Platelet Activation and Atherosclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Tapping into Mitochondria to Find Novel Targets for Diabetes Complications
Current Drug Targets Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk
Current Pharmaceutical Design Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics
Current Respiratory Medicine Reviews Induction of Myocardial Fibrosis and Hypertrophy by Natriuretic Peptides
Vascular Disease Prevention (Discontinued) Pleiotropic Effects of Nifedipine on Atherosclerosis
Current Pharmaceutical Design Does a Physically Active Lifestyle Attenuate Decline in All Cognitive Functions in Old Age?
Current Aging Science Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews MicroRNA-136 Promotes Vascular Muscle Cell Proliferation Through the ERK1/2 Pathway by Targeting PPP2R2A in Atherosclerosis
Current Vascular Pharmacology Leukopenia Associated with Risperidone Treatment
Current Drug Safety Arterial Stiffness and Type 1 Diabetes: The Current State of Knowledge
Current Diabetes Reviews Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy
Current Vascular Pharmacology